Trial Profile
Effect of empagliflozin in improving beta cell function in patients with type-2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Sep 2016
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 Sep 2016 New trial record